Concateno’s objective is to become the premier provider of substance misuse services globally. They are an AIM (Alternative Investment Market) listed company that is currently focused on acquisition and consolidation within the drug testing market and is backed by an impressive list of supportive shareholders. The group currently comprises of Altrix Healthcare Limited, Euromed Limited, Medscreen limited & TrichoTech Limited. Collectively, the group boasts an unparalelled set of competencies and a wealth of experience. Follow the respective links for more nformation about each company.